Psychostimulant effect of dopaminergic treatment and addictions in Parkinson's disease.

about

The Neuropsychiatric Fluctuations Scale for Parkinson's Disease: A Pilot Study

P2860

Q58575492-B944B06C-4D1D-452C-BEB7-9C4EABDBDB4C

P2860

Psychostimulant effect of dopaminergic treatment and addictions in Parkinson's disease.

Item

http://www.wikidata.org/entity/Q48615659

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年学术文章

@wuu

2017年学术文章

@zh

2017年学术文章

@zh-cn

2017年学术文章

@zh-hans

2017年学术文章

@zh-my

2017年学术文章

@zh-sg

2017年學術文章

@yue

2017年學術文章

@zh-hant

name

Psychostimulant effect of dopaminergic treatment and addictions in Parkinson's disease.

@en

Psychostimulant effect of dopaminergic treatment and addictions in Parkinson's disease.

@nl

type

Item

label

Psychostimulant effect of dopaminergic treatment and addictions in Parkinson's disease.

@en

Psychostimulant effect of dopaminergic treatment and addictions in Parkinson's disease.

@nl

prefLabel

Psychostimulant effect of dopaminergic treatment and addictions in Parkinson's disease.

@en

Psychostimulant effect of dopaminergic treatment and addictions in Parkinson's disease.

@nl

P1476

Psychostimulant effect of dopaminergic treatment and addictions in Parkinson's disease.

@en

P2093

Amélie Bichon

http://www.w3.org/2001/XMLSchema#string

Andrea Kistner

http://www.w3.org/2001/XMLSchema#string

Anna Castrioto

http://www.w3.org/2001/XMLSchema#string

Benoit Delpont

http://www.w3.org/2001/XMLSchema#string

Christian Lüscher

http://www.w3.org/2001/XMLSchema#string

Emmanuel Broussolle

http://www.w3.org/2001/XMLSchema#string

Emmanuelle Schmitt

http://www.w3.org/2001/XMLSchema#string

Eugénie Lhommée

http://www.w3.org/2001/XMLSchema#string

Hélène Klinger

http://www.w3.org/2001/XMLSchema#string

Jean-Louis Quesada

http://www.w3.org/2001/XMLSchema#string

P2860

Neurocircuitry of addiction

Hedonistic homeostatic dysregulation in patients with Parkinson's disease on dopamine replacement therapies

Neurobiologic Advances from the Brain Disease Model of Addiction

Drugs abused by humans preferentially increase synaptic dopamine concentrations in the mesolimbic system of freely moving rats

The hidden sister of motor fluctuations in Parkinson's disease: A review on nonmotor fluctuations.

Loss of dopaminergic nigrostriatal neurons accounts for the motivational and affective deficits in Parkinson's disease.

Dopamine ups and downs in vulnerability to addictions: a neurodevelopmental model.

Questionnaire for Impulsive-Compulsive Disorders in Parkinson's Disease-Rating Scale.

Drug-evoked synaptic plasticity in addiction: from molecular changes to circuit remodeling

Neuroscience of behavioral and pharmacological treatments for addictions

P304

1566-1573

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1002/MDS.27101

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Pierre Pollak

Paul Krack

Valérie Fraix

P577

2017-07-24T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

28737225

http://www.w3.org/2001/XMLSchema#string

P921

dopamine

Psychostimulant effect of dopaminergic treatment and addictions in Parkinson's disease.

about

P2860

P2860

Psychostimulant effect of dopaminergic treatment and addictions in Parkinson's disease.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P407

P433

P478

P50

P577

P698

P921

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P407

P433

P478

P50

P577

P698

P921